维普中文期刊产品整合服务
55篇 您的检索式:作者名="Janney CA"
    题名 作者 年代 出处 被引量
1The continuing in- crease in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis 显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
2The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma:a surveillance,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,:1
3The continuing increase in the incidence of primary central nervous system non- Hodgkin lymphoma: a surveillance, epidemiology, and end re- sults analysis 显示文摘Olson JE Janney CA Rao RD 2006Cancer2006,98,:1
4The continuing increase in the incidence of primary central nervous system non Hodgkin lym- phoma : a surveillance, epidemiology, and end results analysis显示文摘Olson JE 1 Janney CA Rao RD 2002Cancer2002,95,7:1
5The continuing increase the incidence of primary central nervous system non-Hodgkin lymphoma:A surveillanc e,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
6The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma:a surveillance,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
7The continuing in- crease in the incidence of primary central nervous system non- Hodgkin lyrephoma: a surveillance, epidemiology, and end results analysis 显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
8Host genetic polymorphism analysis in cervical cancer显示文摘Calhoun ES McGovern RM Janney CA 2002Clin Chem2002,48,8:1
9The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and endresults analysis 显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
10Gender,mental health service use and objectively measured physicalactivity:Data from the National Health and NutritionExamination Survey(NHANES 2003 - 2004)显示文摘Janney CA Richardson CR Holleman RG 2008Mental Healthand Physical Activity2008,1,1:1
11The Physical Activity Scale for the Elderly (PASE):development and evaluation显示文摘Washburn RA Smith KW Jette AM Janney CA 0,,:1
12The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma:a surveillance,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
13The continuing increase in the incidence of primary central nervous system non - Hodgkin lymphoma: A surveillance, epidemiology, and end results analysis 显示文摘Olson JE Janney CA Rao RD etal 2002Cancer2002,95,7:1
14The continuing increase in the incidence of primary central nervous system non-Hodgkin lym-phoma:a surveillance,epidemiology,and end results analysis显示文摘Obon JE Janney CA Rao RD 2002Cancer2002,95,7:1
15High expression levels of insulin-like growth factor-Ⅰ receptor predict poor survival among women with clear-cell renal cell carcinoma 显示文摘Parker AS Cheville JC Janney CA 2002Hum Pathol2002,33,8:1
16The continuing increase in the incidence of primary central nervous system non -Hodgkin lymphoma:a surveillance,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
17Host genetic polymorphism analysis in cervical cancer 显示文摘Calhoun ES Mcgovern RM Janney CA 2002Clin Chem2002,48,8:1
18The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis 显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
19The continuing increase in the incidence of primary central nervous system lymphoma:a surveillance,epidemiology,and end results analysis显示文摘Olson JE Janney CA Rao RD 2002Cancer2002,95,7:1
20The continuing increase in the incidence of primarycentralnervous system non-Hodgkin lymphoma:a surveillance,epidemiology,and end result analysis显示文摘Olson JE Janney CA Rao RD 2009Cancer2009,95,7:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费